Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function

High-dose methotrexate (MTX; ≥1 g/m(2)) is a renally eliminated and nephrotoxic first-line therapy for central nervous system (CNS) lymphoma. Creatinine-based estimation of renal function is the recommended approach to dosing MTX in these cases, but nonrenal determinants of creatinine production and...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreto, Jason N., McClanahan, Allison L., Rule, Andrew D., Thompson, Carrie A., Frazee, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892267/
https://www.ncbi.nlm.nih.gov/pubmed/29780646
http://dx.doi.org/10.1155/2018/7169897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892267/
https://www.ncbi.nlm.nih.gov/pubmed/29780646
http://dx.doi.org/10.1155/2018/7169897

Ejemplares similares